Stocks
Zafgen IncZFGN
HealthcareBiotechnology
A clinical-stage biopharmaceutical company focused on developing therapies for metabolic and rare diseases, including Prader-Willi syndrome and other hyperphagic conditions. Its lead candidate, ZGN-1061, targets methionine aminopeptidase 2 to improve metabolic outcomes. Investors track Zafgen for its pipeline progress and regulatory milestones in the obesity and metabolic disorder space.
Congressional Interest in Zafgen Inc (ZFGN)
1 member of Congress has disclosed 1 trade in Zafgen Inc (ZFGN), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ZFGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-04-02 | JAMES B. RENACCI | sell | $1K-$15K |